LifeMD Non-GAAP EPS of -$0.29, revenue of $27.42M

• LifeMD press release (NASDAQ:LFMD): Q4 Non-GAAP EPS of -$0.29.
• Revenue of $27.42M (+112.7% Y/Y).
• Guidance: For the First Quarter 2022, the company expects:
• Revenue to total between $30 million and $32 million
• Adjusted EBITDA between $(6) million and $(7) million.
• For the Full Year 2022, the company expects:
• Revenue to total between $142 million and $148 million
• Adjusted EBITDA between $(14) million and $(20) million